Stop by the #AACR26 Antibody-Drug Conjugates and Linker Engineering poster session to see work by Samuel Lawn and colleagues on the FRα-t...

Clinical Cancer Research· @CCR_AACR · X·2026-04-21 00:07· 2026-04-21Score60

Body · original

Stop by the #AACR26 Antibody-Drug Conjugates and Linker Engineering poster session to see work by Samuel Lawn and colleagues on the FRα-targeting antibody drug conjugate ZW191 bearing a novel TOP1 inhibitor and catch the related simultaneous publication.
https://
brnw.ch/21x1Lr5

Heat 7 · 5 likes · 0 replies · 2 reposts

Conference abstracts

CT306NCT06555744matched by 代号 ZW191

Phase 1 first-in-human multicenter open-label study of ZW191, a folate receptor α (FRα)-targeting antibody-drug conjugate (ADC), in patients with advanced solid tumors: Part 1 dose-escalation results

Patricia LoRusso, David Sommerhalder, Kosei Hasegawa, Kenichi Harano, David S. Tan, Noboru Yamamoto, David M. O’Malley, Kathleen N. Moore, Sarah E. Church, Lin Lu, Sabeen Mekan, Pranshul Chauha, Jung-Yun Lee

Read the abstract →

Source: Clinical Cancer Research · x.com